However, conflicting results regarding the association of ELAC2 gene polymorphisms and the occurrence of PCa have been obtained in different populations around the world, testifying to the genetic complexity and heterogeneity of prostate cancer susceptibility [17, 19–25]. This evidence concerns the gene ELAC2 and prostate cancer.